These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23763618)

  • 1. The effect of rocuronium and sugammadex on neuromuscular blockade in a child with congenital myotonic dystrophy type 1.
    Pickard A; Lobo C; Stoddart PA
    Paediatr Anaesth; 2013 Sep; 23(9):871-3. PubMed ID: 23763618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthesia for laparoscopic surgery in a patient with myotonic dystrophy (Steinert's disease): beneficial use of sugammadex, but incorrect use of pethidine: a case report.
    Mavridou P; Dimitriou V; Margaritis A; Manataki A
    Acta Anaesthesiol Belg; 2011; 62(2):101-4. PubMed ID: 21919378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
    Kim JE; Chun HR
    Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
    de Boer HD; van Esmond J; Booij LH; Driessen JJ
    Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugammadex reversal of rocuronium-induced neuromuscular blockade in two types of neuromuscular disorders: Myotonic dystrophy and spinal muscular atrophy.
    Stewart PA; Phillips S; De Boer HD
    Rev Esp Anestesiol Reanim; 2013 Apr; 60(4):226-9. PubMed ID: 22947194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
    Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
    Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rocuronium and sugammadex in myotonic dystrophy.
    Baumgartner P
    Anaesth Intensive Care; 2010 Sep; 38(5):959-60. PubMed ID: 20865895
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular transmission: new concepts and agents.
    de Boer HD
    J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of profound neuromuscular blockade with sugammadex after failure of rapid sequence endotracheal intubation: a case report.
    Barbosa FT; da Cunha RM
    Rev Bras Anestesiol; 2012; 62(2):281-4. PubMed ID: 22440384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.
    Ozmete O; Bali C; Cok OY; Turk HE; Ozyilkan NB; Civi S; Aribogan A
    J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal.
    Porter MV; Paleologos MS
    Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study.
    Cammu G; Coart D; De Graeve K; Beelen R
    Acta Anaesthesiol Belg; 2012; 63(2):69-73. PubMed ID: 23136807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful use of sugammadex in a muscular dystrophy patient].
    Yamada M; Kimura T
    Masui; 2011 Oct; 60(10):1205-6. PubMed ID: 22111367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.